Rozeta Sokou
Nicoletta Iacovidou
Stavroula Parastatidou
Aikaterini Konstantinidi- 1Neonatal Intensive Care Unit, Nikaia General Hospital “Aghios Panteleimon”, Piraeus, Greece
- 2Department of Neonatology Aretaieio Hospital, National and Kapodistrian University of Athens, Athens, Greece
- 3Neonatal Intensive Care Unit, University General Hospital Attikon, Athens, Greece
Editorial on the Research Topic
Filling the knowledge gap of neonatal hemostasis
“Developmental hemostasis” is a term used to describe the dynamic process of gradual hemostatic maturation from fetal life through the adulthood (1). Neonates are born with a hemostatic “deficit” related to the gestational age, the immaturity of hepatic function, the varying vitamin K concentrations and the developmental stage of vascular endothelium (2).
Despite the continuous advances in neonatal hematology, there remain many gaps in our understanding of the hemostatic mechanisms in this delicate population. The existing significant qualitative and quantitative differences of coagulation factors between neonates and adults make the interpretation of hemostatic alterations in neonates difficult, resulting in pitfalls and dilemmas that do not occur in adults (3). In neonates platelet counts are similar to adults, as it is reported in the literature, yet there are developmental differences with respect to platelet function. It is noteworthy, that despite platelet hyporeactivity in neonates, primary hemostasis is not impaired; bleeding times (BTs) in healthy term neonates as well as closure times (using the Platelet Function Analyzer-PFA-100) are found to be shorter than older children and adults (4, 5).
Conventional coagulation tests such as prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), although commonly used for the assessment of coagulopathies, present limitations; they do not provide adequate information on platelet function and fibrinolysis (2, 6, 7). Moreover, in neonates the presence of abnormal values of these tests are not always associated with a clinically relevant disease and what is more important, their predictive value for bleeding is poor. On the other hand, viscoelastic tests such as Thromboelastography/Thromboelastometry (TEG/ROTEM), based on the interactions between blood cells and coagulation factors can estimate the dynamics of blood coagulation from the activation of clotting factors to clot lysis. Thus, they may represent a useful tool for studying the coagulation status of neonates (7). Several studies have conducted aiming at establishing reference ranges for the coagulation parameters in neonates but there is no study establishing cut-off values for bleeding risk in this population. This fact has led clinicians to focus on correcting coagulation values outside the reference ranges and to transfuse critically ill neonates without evidence of bleeding (2).
The management of hemostatic derangements in neonates represents a challenge for neonatologists, as neonatal bleeding or thromboembolic events are potentially life-threatening situations calling for accurate diagnostic tests, better markers for treatment decision making, and also for a new therapeutic approach.
The Research Topic “Filling the knowledge gap of neonatal hemostasis” includes four novel and original contributions in the field of neonatal hemostasis aiming at highlighting recent advances on pathophysiology, diagnosis and prediction of hemostatic derangements in sick neonates and providing new insights in the management of specific clinical settings.
In this collection of articles, Amelio et al. investigate the hemostatic profile of 26 full term and 19 late preterm neonates hospitalized in a Neonatal Intensive Care Unit (NICU) during the first 72 h of life, using a novel device named Viscoelastic Coagulation Monitor (VCM®); they studied the relationship between the values of VCM parameters and conventional coagulation tests. Additionally, they evaluate the differences between the values of VCM parameters found in their cohort with relevant adult reference values displayed by the same device.
In healthy neonates, the hemostatic system although immature is functionally balanced, yet this balance may easily be disturbed in the context of critical illness such as sepsis, birth asphyxia, major surgery, liver disease, extracorporeal membrane support (ECMO) resulting in bleeding or thromboembolic events (8).
Cortesi et al. provide an overview of different monitoring tests and approaches, with focus on the role of point-of-care (POC) viscoelastic assays in neonatal ECMO. The authors come to the conclusion that the best strategy to monitor and guide anticoagulation therapy is still unknown; a combination of multiple laboratory assays appears to be the best option for the assessment of the coagulation status in neonates undergoing ECMO.
Regarding platelet functionality of neonates with fetal growth restriction (FGR), Kollia et al. evaluate platelet responsiveness using PFA-100 in cord blood samples and report that FGR neonates demonstrate a relatively hyporesponsive platelet phenotype, especially those who are preterm, compared to healthy neonates.
Inflammation and hemostasis are interrelated pathophysiologic processes that considerably affect each other. In this two-way relationship, inflammation promotes coagulation activation which in turn influences inflammatory activity. The bi-directional relationship between coagulation and inflammation appears to play a key role in the process underling multi-organ dysfunction in septic patients (9).
In the context of this relationship, Sokou et al. develop and validate a neonatal sepsis diagnostic (NeoSeD) model for hospitalized neonates undergoing evaluation for sepsis, combining ROTEM parameters and maternal/neonatal risk factors, clinical and laboratory variables. Authors conclude that this score may contribute to the timely diagnosis, optimal management, and potential improvement of short-and long-term outcome of septic neonates.
Neonatal hemostasis is a serious issue not adequately studied due to difficulties attributed to very nature of the neonatal population. Thorough comprehension of the developmental stage of hemostasis and the underlying pathophysiology is considered as a prerequisite for the appropriate evaluation of risk factors and proper management of hemostatic derangements in neonatal population.
This Research Topic attempts to illuminate the field of neonatal hemostasis and provide interesting and documented data as well as stimuli for further research. However, there remains an urgent need for filling the gaps in knowledge of neonatal transfusion therapy along with the establishment of international collaboration to develop evidence-based guidelines.
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to this research topic. RS and AK conceptualized and wrote the first draft of this manuscript. NI and SP contributed to manuscript revision, read, and approved the submitted version. All authors contributed to the article and approved the submitted version.
Acknowledgments
The authors would like to thank those who contributed manuscripts to this Research Topic of Frontiers in Pediatrics.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood. (1987) 70(1):165–72. doi: 10.1182/blood.V70.1.165.165
2. Sokou R, Parastatidou S, Konstantinidi A, Tsantes AG, Iacovidou N, Doxani C, et al. Fresh frozen plasma transfusion in the neonatal population: a systematic review. Blood Rev. (2022) 55:100951. doi: 10.1016/j.blre.2022.100951
3. Monagle P, Ignjatovic V, Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev. (2010) 24(2):63–8. doi: 10.1016/j.blre.2009.12.001
4. Andrew M, Paes B, Bowker J, Vegh P. Evaluation of an automated bleeding time device in the newborn. Am J Hematol. (1990) 35(4):275–7. doi: 10.1002/ajh.2830350411
5. Boudewijns M, Raes M, Peeters V, Mewis A, Cartuyvels R, Magerman K, et al. Evaluation of platelet function on cord blood in 80 healthy term neonates using the platelet function analyser (PFA-100): shorter in vitro bleeding times in neonates than adults. Eur J Pediatr. (2003) 162(3):212–3. doi: 10.1007/s00431-002-1093-7
6. Goel R, Josephson CD. Recent advances in transfusions in neonates/infants. F1000Res. (2018) 7:609. doi: 10.12688/f1000research.13979.1
7. Konstantinidi A, Sokou R, Parastatidou S, Lampropoulou K, Katsaras G, Boutsikou T, et al. Clinical application of thromboelastography/thromboelastometry (TEG/TEM) in the neonatal population: a narrative review. Semin Thromb Hemost. (2019) 45(5):449–57. doi: 10.1055/s-0039-1692210
8. Revel-Vilk S. The conundrum of neonatal coagulopathy. Hematology Am Soc Hematol Educ Program . (2012) 2012:450–4. doi: 10.1182/asheducation-2012.1.450
Keywords: developmental hemostasis, neonatal hemostasis, hematology, coagulopathy, neonates, bleeding events
Citation: Sokou R, Iacovidou N, Parastatidou S and Konstantinidi A (2023) Editorial: Filling the knowledge gap of neonatal hemostasis. Front. Pediatr. 10:1110481. doi: 10.3389/fped.2022.1110481
Received: 28 November 2022; Accepted: 5 December 2022;
Published: 4 January 2023.
Edited and Reviewed by: Eugene Dempsey, University College Cork, Ireland
© 2023 Sokou, Iacovidou, Parastatidou and Konstantinidi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rozeta Sokou c29rb3Vyb3pldGFAeWFob28uZ3I=
Specialty Section: This article was submitted to Neonatology, a section of the journal Frontiers in Pediatrics